MINIMALLY INVASIVE SURGERY HOSPITAL — History
CCN 170199 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$14M
Latest Revenue (FY2022)
+18.1%
Revenue CAGR (3yr)
21.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $10M | $10M | $14M | +37.6% | +18.1% |
| Operating Expenses | $8M | $13M | $11M | -11.2% | +16.1% |
| Operating Margin | 18.4% | -22.3% | 21.2% | +195.0% | +7.2% |
| Net Income | $2M | $-2M | $3M | +230.8% | +26.6% |
| Licensed Beds | 9 | 9 | 7 | -22.2% | -11.8% |
| Total Patient Days | 67 | 81 | 94 | +16.0% | +18.4% |
| Medicare Day % | 66% | 59% | 48% | -19.2% | -14.6% |
| Medicaid Day % | nan% | nan% | 16% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +39.6% ($10M → $14M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+18.1%
This Hospital
+7.6%
State Avg
Latest Margin
21.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $16M | 22.5% |
| FY2024 (proj) | $19M | 23.9% |
| FY2025 (proj) | $21M | 25.3% |